Joe Tippens founded the protocol (1) following he was informed a Tale about a scientist at Merck Animal Health that had been doing cancer exploration on mice. The study integrated injecting differing types of cancers into distinct mice overall body parts. The researchers learned, by trial and error, an item of their canine item line, fenbendazol